Publications by authors named "Timothy Pond"

Claim this Profile
M
Mu-opioid receptor availability in patients with opioid use disorder treated with either methadone or buprenorphine.
Jacob G Dubroff, Chia-Ju Hsieh, Hsiaoju Lee, Elizabeth J Li, Alexander Schmitz, Timothy Pond

medRxiv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic effects of a single-dose nutritional ketone ester supplement on brain glucose and ketone metabolism in alcohol use disorder.
Xinyi Li, Anthony J Young, Zhenhao Shi, Juliana Byanyima, Sianneh Vesslee, Timothy Pond

medRxiv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Ketone Supplementation Dampens Subjective and Objective Responses to Alcohol: Evidence From a Preclinical Rat Study and a Randomized, Cross-Over Trial in Healthy Volunteers.
Xinyi Li, Zhenhao Shi, Dustin R Todaro, Timothy Pond, Juliana I Byanyima

Int J Neuropsychopharmacol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Ketone supplementation dampens subjective and objective responses to alcohol in rats and humans.
Xinyi Li, Zhenhao Shi, Dustin Todaro, Timothy Pond, Juliana Byanyima

bioRxiv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An intensive longitudinal examination of topiramate treatment for alcohol use disorder: a secondary analysis of data from a randomized controlled trial.
Victoria R Votaw, Katie Witkiewitz, M Lee Van Horn, Richard C Crist, Timothy Pond

Addiction· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral and Central Iron Measures in Alcohol Use Disorder and Aging: A Quantitative Susceptibility Mapping Pilot Study.
Aiden R Adams, Xinyi Li, Juliana I Byanyima, Sianneh A Vesslee, Thanh D Nguyen, Timothy Pond

Int J Mol Sci· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, placebo-controlled, pharmacogenetic study of ondansetron for treating alcohol use disorder.
Chamindi Seneviratne, David A Gorelick, Kevin G Lynch, Clayton Brown, Danielle Romer, Timothy Pond

Alcohol Clin Exp Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-treatment effects of topiramate on alcohol-related outcomes: A combined analysis of two placebo-controlled trials.
Henry R Kranzler, Richard Feinn, Timothy Pond, Emily Hartwell, Joel Gelernter

Addict Biol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined analysis of the moderating effect of a GRIK1 polymorphism on the effects of topiramate for treating alcohol use disorder.
Henry R Kranzler, Emily E Hartwell, Richard Feinn, Timothy Pond, Katie Witkiewitz

Drug Alcohol Depend· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
World Health Organization risk drinking levels as a treatment outcome measure in topiramate trials.
Emily E Hartwell, Richard Feinn, Katie Witkiewitz, Timothy Pond, Henry R Kranzler

Alcohol Clin Exp Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of topiramate on neural responses to alcohol cues in treatment-seeking individuals with alcohol use disorder: preliminary findings from a randomized, placebo-controlled trial.
Reagan R Wetherill, Nathaniel Spilka, Kanchana Jagannathan, Paige Morris, Danielle Romer, Timothy Pond

Neuropsychopharmacology· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective randomized pharmacogenetic study of topiramate for treating alcohol use disorder.
Henry R Kranzler, Paige E Morris, Timothy Pond, Richard C Crist, Kyle M Kampman

Neuropsychopharmacology· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Prospective randomized pharmacogenetic study of topiramate for treating alcohol use disorder.
Henry R Kranzler, Paige E Morris, Timothy Pond, Richard C Crist, Kyle M Kampman

Neuropsychopharmacology· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Recent Alcohol Consumption Level on Neurocognitive Performance in HIV+ Individuals.
Kara R Douglas-Newman, Rachel V Smith, Mary V Spiers, Timothy Pond, Henry R Kranzler

Addict Disord Their Treat· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-efficacy mediates the effects of topiramate and GRIK1 genotype on drinking.
Henry R Kranzler, Stephen Armeli, Reagan Wetherill, Richard Feinn, Howard Tennen, Timothy Pond

Addict Biol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Smoking and Cellular Telephone Use Among Pregnant Women Seeking Prenatal Care: Opportunities for Intervention.
Jennifer Gilbert, Robert Schnoll, Mary F Morrison, Sindhu K Srinivas, Timothy Pond

Addict Disord Their Treat· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Posttreatment effects of topiramate treatment for heavy drinking.
Henry R Kranzler, Reagan Wetherill, Richard Feinn, Timothy Pond, Joel Gelernter

Alcohol Clin Exp Res· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topiramate's reduction of body mass index in heavy drinkers: lack of moderation by a GRIK1 polymorphism.
Henry R Kranzler, Richard Feinn, Joel Gelernter, Timothy Pond, Jonathan Covault

Exp Clin Psychopharmacol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dutasteride reduces alcohol's sedative effects in men in a human laboratory setting and reduces drinking in the natural environment.
Jonathan Covault, Timothy Pond, Richard Feinn, Albert J Arias, Cheryl Oncken

Psychopharmacology (Berl)· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A GABRA2 variant is associated with increased stimulation and 'high' following alcohol administration.
Albert J Arias, Jonathan Covault, Richard Feinn, Timothy Pond, Bao-Zhu Yang

Alcohol Alcohol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topiramate treatment for heavy drinkers: moderation by a GRIK1 polymorphism.
Henry R Kranzler, Jonathan Covault, Richard Feinn, Stephen Armeli, Howard Tennen, Timothy Pond

Am J Psychiatry· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis